2140305-18-4
2140305-18-4
Chemical Structure
Zafirlukast-13C,d3
Synonym(s): ICI 204219-13C,d3
- CAS. Nr.: 2140305-18-4
- Formula:C3013CH30D3N3O6S
- Molecular Weight:579.69
IUPAC Name: 2-(5-((2-oxooxazolidin-4-yl)methyl)-1H-indol-3-yl-4,6,7-d3)acetic acid
InChIKey: YEEZWCHGZNKEEK-LBDFIVMYSA-N
SMILES: O=C(NC1=CC(C(CC2=CC=C(C(NS(=O)(C3=C(C)C=CC=C3)=O)=O)C=C2O[13C]([2H])([2H])[2H])=CN4C)=C4C=C1)OC5CCCC5
Biological Activity: Zafirlukast-13C,d3 is the 13C- and deuterium labeled Zafirlukast. Zafirlukast (ICI 204219) is a potent orally active leukotriene D4 (LTD4) receptor antagonist. Zafirlukast shows anti-asthmatic, anti-inflammatory and anti-bacterial effects.
| Art. -Nr. | Produktname | Reinheit | Beschreibung | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Zafirlukast-13C,d3 | Zafirlukast-13C,d3 is the 13C- and deuterium labeled Zafirlukast. Zafirlukast (ICI 204219) is a potent orally active leukotriene D4 (LTD4) receptor antagonist. Zafirlukast shows anti-asthmatic, anti-inflammatory and anti-bacterial effects. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Zafirlukast (Standard) | 99.15% | Zafirlukast (Standard) is the analytical standard of Zafirlukast. This product is intended for research and analytical applications. Zafirlukast (ICI 204219) is a potent orally active leukotriene D4 (LTD4) receptor antagonist. Zafirlukast shows anti-asthmatic, anti-inflammatory and anti-bacterial effects. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Zafirlukast-13C,d6 | Zafirlukast-13C,d6 is the 13C- and deuterium labeled Zafirlukast. Zafirlukast (ICI 204219) is a potent orally active leukotriene D4 (LTD4) receptor antagonist. Zafirlukast shows anti-asthmatic, anti-inflammatory and anti-bacterial effects. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Zafirlukast-d7 | Zafirlukast-d7 is the deuterium labeled Zafirlukast. Zafirlukast (ICI 204219) is a potent orally active leukotriene D4 (LTD4) receptor antagonist. Zafirlukast shows anti-asthmatic, anti-inflammatory and anti-bacterial effects. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Zafirlukast-d6 | Zafirlukast-d6 is deuterated labeled Zafirlukast (HY-17492). Zafirlukast (ICI 204219) is a potent orally active leukotriene D4 (LTD4) receptor antagonist. Zafirlukast shows anti-asthmatic, anti-inflammatory and anti-bacterial effects. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Zafirlukast | 99.87% | Zafirlukast (ICI 204219) is a potent orally active leukotriene D4 (LTD4) receptor antagonist. Zafirlukast shows anti-asthmatic, anti-inflammatory and anti-bacterial effects. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
